Colin Clive Dalton
Chairman at Coalesce Product Development Ltd.
Profile
Colin Clive Dalton is currently the Chairman at Coalesce Product Development Ltd.
He previously worked as the Director of Intellectual Property & Corporate Affairs at Vectura Group Ltd., Director of Business Development at GlaxoSmithKline Biologicals NV, Director of Corporate Development at Quadrant Healthcare Plc and Innovata Ltd., Director at ImCyse SA, Scientist of Fermentation at BP Plc, and Manager of Technical Business Development at British Sugar Plc.
Dr. Dalton received a doctorate degree from the University of Leicester in 1977.
Colin Clive Dalton active positions
Companies | Position | Start |
---|---|---|
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022. | Chairman | - |
Former positions of Colin Clive Dalton
Companies | Position | End |
---|---|---|
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Director/Board Member | - |
British Sugar Plc
British Sugar Plc Agricultural Commodities/MillingProcess Industries British Sugar Plc manufactures and distributes sugar. The company supplies cereals, confectionary, drinks, ice-cream & other dairy products, pharmaceutical & nutraceutical products, condiments, sauces, and canned goods. It was founded in 1936 and is headquartered in Peterborough, UK. | Corporate Officer/Principal | - |
BP PLC | Corporate Officer/Principal | - |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Corporate Officer/Principal | - |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Corporate Officer/Principal | - |
Training of Colin Clive Dalton
University of Leicester | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BP PLC | Energy Minerals |
Private companies | 7 |
---|---|
Innovata Ltd.
Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Health Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
British Sugar Plc
British Sugar Plc Agricultural Commodities/MillingProcess Industries British Sugar Plc manufactures and distributes sugar. The company supplies cereals, confectionary, drinks, ice-cream & other dairy products, pharmaceutical & nutraceutical products, condiments, sauces, and canned goods. It was founded in 1936 and is headquartered in Peterborough, UK. | Process Industries |
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022. | Health Technology |
- Stock Market
- Insiders
- Colin Clive Dalton